Amyotrophic Lateral Sclerosis Current Events | Amyotrophic Lateral Sclerosis News | 8
|
| Page
8 of
15 |
296 Results |
|
|
|
Sort By:
Page Views | Date |
Compound shows potential for slowing progression of ALS
A chemical cousin of a drug currently used to treat sepsis dramatically slows the progression of amyotrophic lateral sclerosis, better known as ALS or Lou Gehrig's disease, in mice. view more (2009-10-20)
Men leave: Separation and divorce far more common when the wife is the patient
A woman is six times more likely to be separated or divorced soon after a diagnosis of cancer or multiple sclerosis than if a man in the relationship is the patient, according to a study that examined the role gender played in so-called "partner abandonment." The study also found that the longer the marriage the more likely it would... view more... (2009-11-11)
Disease activity increases after MS patients stop drug
People with multiple sclerosis who stop taking the drug natalizumab may experience a rebound increase in disease activity. view more (2007-09-13)
'CARS' imaging reveals clues to myelin damage
Researchers have discovered that calcium ions could play a crucial role in multiple sclerosis by activating enzymes that degrade the fatty sheath that insulates nerve fibers. view more (2007-06-28)
Leaky blood vessels open up nerve cells to toxic assault in Lou Gehrig's disease
Leaky blood vessels that lose their ability to protect the spinal cord from toxins may play a role in the development of amyotrophic lateral sclerosis, better known as ALS or Lou Gehrig's disease, according to research published in the April issue of Nature Neuroscience. view more (2008-04-08)
COPAXONE® may repair nerve damage in Multiple Sclerosis patients
Clinical research data published in the December issue of Multiple Sclerosis provided evidence that COPAXONE® (glatiramer acetate injection) may offer protection from axonal injury and induced neuronal metabolic recovery in patients with relapsing remitting multiple sclerosis (RRMS). view more (2005-11-15)
Cannabinoids in Multiple Sclerosis Trial Fully Recruited
On Monday the Peninsula Medical School will announce that the Medical Research Council sponsored trial investigating the effectiveness of cannabinoids on the symptoms of Multiple Sclerosis has fully recruited its quota of 667 patients. Dr John Zajicek, consultant neurologist and one of the Principal Investigators of the study, said: "There... view more... (2002-10-11)
RSRT Advisor Makes Significant Discovery with Potential for Novel Therapeutic Approaches
A paper published online today in Nature Neuroscience reveals the presence of methyl CpG binding protein 2 (MeCP2) in glia. MeCP2 is a protein associated with a variety of neurological disorders, including Rett Syndrome, the most physically disabling of the autism spectrum disorders. view more (2009-02-23)
Designing latest-generation antennae for communications satellites
For his PhD thesis, the engineer, Jorge Teniente Vallinas, has developed a method for designing antennas used in satellites such as Hispasat. The PhD, at the Public University of Navarre, was awarded the second prize in the latest edition of the Rosina Ribalta Awards from the Epson Ibérica Foundation for the best PhD thesis in the field of... view more... (2004-02-17)
Mayo Clinic identifies 2 genes as potential therapeutic targets for multiple sclerosis
A Mayo Clinic study has found that two genes in mice were associated with good central nervous system repair in multiple sclerosis (MS). view more (2009-09-11)
Stanford doctors spotlight fatal flaw in multiple sclerosis drug trial
When Anita Louise Smith enrolled in an experimental drug trial in 2002 in Colorado, she had a diagnosis of multiple sclerosis but no symptoms and was looking to reduce the chances of being ravaged by the disease. Last year, she died at the age of 46 from an infection linked to the drug. view more (2006-03-03)
WHAT FUTURE FOR CANNABIS?
The potential therapeutic effects of cannabis are outlined in a review in the May issue of THE LANCET NEUROLOGY. The review is published in anticipation of results from randomised trials expected later this year investigating possible benefits of the drug for people with multiple sclerosis. The first cannabis-based medicines are currently being... view more... (2003-04-16)
Genetic differences may help explain response to multiple sclerosis treatment
By comparing the DNA of patients with multiple sclerosis whose symptoms are reduced by interferon beta therapy to the DNA of those who continue to experience relapses, researchers may have identified important genetic differences between the two. view more (2008-01-15)
Nervous system may be culprit in deadly muscle disease
Brain may win out over brawn as the primary cause of breathing problems in children with a severe form of muscular dystrophy known as Pompe disease. view more (2009-05-26)
Photoselective film proves effective for controlling height in potted gardenia plants
To grow the high-quality potted plants preferred by consumers, many growers use chemical "regulators" designed to affect plant growth and development. view more (2009-05-04)
Weizmann Institute suggests that immune cells help to maintain cognition and brain cell renewal
A team of scientists at the Weizmann Institute of Science, led by Prof. Michal Schwartz of the Neurobiology Department, has come up with new findings that may have implications in delaying and slowing down cognitive deterioration in old age. view more (2006-01-16)
Muscle patterns in women may be linked to at risk positioning for ACL tears
Research suggests that training programs for females to restore balance between hamstring and quadriceps muscles to better support knee joints could help reduce the disproportionately high number of ACL tears in female athletes. view more (2007-09-19)
Eye test peers into heat-related multiple sclerosis symptoms
A bodysuit that heats or cools a patient, combined with painless measurements of eye movements, is providing multiple sclerosis researchers at UT Southwestern Medical Center with a new tool to study the mysterious link between body temperature and severity of MS symptoms. view more (2008-03-24)
Brain protein central to both Parkinson's, drug addiction identified
Scientists have identified a protein that appears not only to be central to the process that causes Parkinson's disease but could also play a role in muting the high from methamphetamine and other addictive drugs. view more (2009-04-30)
Epstein-Barr Virus May Be Associated with Progression of MS
Epstein-Barr virus (EBV), the pathogen that causes mononucleosis, appears to play a role in the neurodegeneration that occurs in persons with multiple sclerosis, researchers at the University at Buffalo and the University of Trieste, Italy, have shown. view more (2009-03-03)
|
|
| Page
8 of
15 |
296 Results |
|
|
|
Sort By:
Page Views | Date |
|
